Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma.
Ulrich DührsenMareike TomettenFrank KroschinskyArnold GanserStefan IbachStefanie BertramAndreas HuettmannPublished in: Blood cancer journal (2021)
Keyphrases